Hybrid pet/MRI cameras combine metabolic and morphological data with 95% staging metastatic disease sensitivity in HER2-positive cancers; standardized uptake values (SUVs) and ADC are complementary to the treatment response [68]. The gene discussed is ERBB2; the disease is cancer.